169 related articles for article (PubMed ID: 15385640)
1. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.
Rao BM; Driver I; Lauffenburger DA; Wittrup KD
Mol Pharmacol; 2004 Oct; 66(4):864-9. PubMed ID: 15385640
[TBL] [Abstract][Full Text] [Related]
2. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth.
Rao BM; Driver I; Lauffenburger DA; Wittrup KD
Biochemistry; 2005 Aug; 44(31):10696-701. PubMed ID: 16060678
[TBL] [Abstract][Full Text] [Related]
3. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
Imbert V; Rezzonico R; Reichenbach P; Nabholz M
Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity.
Rao BM; Girvin AT; Ciardelli T; Lauffenburger DA; Wittrup KD
Protein Eng; 2003 Dec; 16(12):1081-7. PubMed ID: 14983090
[TBL] [Abstract][Full Text] [Related]
5. Inducible knockout of the interleukin-2 receptor alpha chain: expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines.
Richardson JH; Waldmann TA; Sodroski JG; Marasco WA
Virology; 1997 Oct; 237(2):209-16. PubMed ID: 9356333
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha.
Alileche A; Goldman CK; Waldmann TA
Biochem Biophys Res Commun; 2001 Aug; 285(5):1302-8. PubMed ID: 11478799
[TBL] [Abstract][Full Text] [Related]
7. Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response.
Fallon EM; Lauffenburger DA
Biotechnol Prog; 2000; 16(5):905-16. PubMed ID: 11027188
[TBL] [Abstract][Full Text] [Related]
8. CD4(-)c-kit(-)CD3epsilon(-)IL-2Ralpha(+) Peyer's patch cells are a novel cell subset which secrete IL-5 in response to IL-2: implications for their role in IgA production.
Kuraoka M; Hashiguchi M; Hachimura S; Kaminogawa S
Eur J Immunol; 2004 Jul; 34(7):1920-9. PubMed ID: 15214040
[TBL] [Abstract][Full Text] [Related]
9. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
10. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15.
Kobayashi H; Carrasquillo JA; Paik CH; Waldmann TA; Tagaya Y
Cancer Res; 2000 Jul; 60(13):3577-83. PubMed ID: 10910071
[TBL] [Abstract][Full Text] [Related]
11. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
[TBL] [Abstract][Full Text] [Related]
12. [Screening of short peptides binding to cell surface interleukin-2 receptor alpha chain].
Liu BY; Zhu P; Luo HB; Fu N
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):971-4. PubMed ID: 16864089
[TBL] [Abstract][Full Text] [Related]
13. Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Barata JT; Keenan TD; Silva A; Nadler LM; Boussiotis VA; Cardoso AA
Haematologica; 2004 Dec; 89(12):1459-67. PubMed ID: 15590396
[TBL] [Abstract][Full Text] [Related]
14. Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rbeta chain and suggest differential roles for the IL-2Ralpha and IL-15Ralpha subunits.
de Jong JL; Farner NL; Sondel PM
Cytokine; 1998 Dec; 10(12):920-30. PubMed ID: 10049515
[TBL] [Abstract][Full Text] [Related]
15. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
[TBL] [Abstract][Full Text] [Related]
18. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
[TBL] [Abstract][Full Text] [Related]
19. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2alpha receptor in membrane lipid rafts.
Li QR; Ma J; Wang H; Li JS
Transplant Proc; 2005 Jun; 37(5):2395-7. PubMed ID: 15964425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
